| __timestamp | Alpine Immune Sciences, Inc. | Catalyst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 10117774 |
| Thursday, January 1, 2015 | 16054000 | 11801342 |
| Friday, January 1, 2016 | 23316000 | 11369941 |
| Sunday, January 1, 2017 | 10626000 | 11375237 |
| Monday, January 1, 2018 | 28970000 | 19919204 |
| Tuesday, January 1, 2019 | 35847000 | 18842752 |
| Wednesday, January 1, 2020 | 27185000 | 16496715 |
| Friday, January 1, 2021 | 58742000 | 16936000 |
| Saturday, January 1, 2022 | 70243000 | 19789000 |
| Sunday, January 1, 2023 | 80904000 | 93150000 |
Unlocking the unknown
In the competitive world of biotechnology, innovation is the lifeblood of success. Alpine Immune Sciences, Inc. and Catalyst Pharmaceuticals, Inc. are two companies that have consistently invested in research and development (R&D) over the past decade. From 2014 to 2023, Alpine Immune Sciences has shown a remarkable growth in R&D spending, increasing by over 560%, from approximately $12 million to $81 million. In contrast, Catalyst Pharmaceuticals, while starting at a similar point, has seen a more modest increase of around 820%, reaching $93 million in 2023.
This trend highlights Alpine's aggressive push towards innovation, particularly in recent years, with a significant spike in 2021. Meanwhile, Catalyst's steady investment reflects a more conservative approach. As these companies continue to innovate, their R&D strategies will be crucial in determining their future success in the biotech industry.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: Gilead Sciences, Inc. and Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: BeiGene, Ltd. and Alpine Immune Sciences, Inc.
R&D Insights: How Intra-Cellular Therapies, Inc. and Alpine Immune Sciences, Inc. Allocate Funds
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Alpine Immune Sciences, Inc.
R&D Insights: How Bio-Techne Corporation and Catalyst Pharmaceuticals, Inc. Allocate Funds
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
Research and Development Investment: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Grifols, S.A. vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Xencor, Inc.
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.